Method for evaluating curative effect of compound glutamine formula on diarrhea-predominant irritable bowel syndromes

A technology of irritable bowel syndrome and glutamine, which is applied in the field of medicine, can solve the problems of dose usage analysis, inability to accurately evaluate the efficacy and advantages of compound glutamine prescriptions for diarrhea-predominant irritable bowel syndrome, and achieve cost Low cost, mature quarantine method and strong reliability

Active Publication Date: 2020-11-10
DIAO GRP CHENGDU PHARMA
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the above-mentioned method is a clinical observation and quantitative test, and does not analyze the different compound glutamine formulations (comprising compound glutamine enteric-coated capsules and compound glutamine gastric-coated capsules) and dosage usage. Accurate evaluation of the curative e

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for evaluating curative effect of compound glutamine formula on diarrhea-predominant irritable bowel syndromes
  • Method for evaluating curative effect of compound glutamine formula on diarrhea-predominant irritable bowel syndromes
  • Method for evaluating curative effect of compound glutamine formula on diarrhea-predominant irritable bowel syndromes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0044] The invention provides a method for evaluating the curative effect of a compound glutamine prescription on diarrhea-predominant irritable bowel syndrome, which mainly includes establishment of an animal model of diarrhea-predominant irritable bowel syndrome, drug administration, index detection and scoring, statistics and evaluation. large processes, such as figure 1 shown. The process of the present invention will be further described below with reference to the accompanying drawings and embodiments, and the modes of the present invention include but not limited to the following embodiments.

[0045] The materials are as follows:

[0046] 1. Drugs and reagents

[0047] Compound glutamine enteric-coated capsules, specification: 0.2g content / capsule, containing 0.12g L-glutamine and 0.08g Sijunzi decoction, batch number: 190407.

[0048]Compound glutamine gastric-soluble capsules, specification: 0.2g content / capsule, containing 0.12g L-glutamine and 0.08g Sijunzi deco...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Login to view more

Abstract

The invention discloses a method for evaluating the curative effect of a compound glutamine formula on diarrhea-predominant irritable bowel syndromes. The method mainly comprises the following steps:I, establishing a diarrhea-predominant irritable bowel syndrome animal model; II, performing medicine application; III, performing index detection and scoring (including general clinical observation,excrement and urine detection, intestinal motility influence observation, visceral sensitivity evaluation and colon tissue pathological examination); and IV, performing counting and evaluation. With the adoption of the scheme, the compound glutamine formula with different dosage forms and different use doses can be accurately evaluated in the aspect of treating diarrhea-predominant irritable bowelsyndromes; and preposed basis and valuable guidance are provided for subsequent continuous optimization of dosage form rationality and dosage use of the compound glutamine formula, and further betterin-depth clinical treatment and research of the diarrhea-predominant irritable bowel syndromes and continuous clarification of IBS curative effects.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a method for evaluating the curative effect of a compound glutamine prescription on diarrhea-type irritable bowel syndrome. Background technique [0002] Irritable bowel syndrome (IBS) is a common chronic intestinal dysfunction disease. Its clinical manifestations are abdominal pain, abdominal distension, and changes in defecation habits and shapes. Most of them are intermittent attacks without organic lesions. Clinically, IBS is often further divided into diarrhea-predominant IBS and constipation-predominant IBS. Due to the unclear etiology and complex pathogenesis of IBS, although there are many treatment methods, the curative effects are not exact. [0003] Compound Glutamine Enteric-Coated Capsules was developed by the applicant (Di'ao Group Chengdu Pharmaceutical Co., Ltd.), and it is used to treat acute and chronic intestinal diseases and intestinal dysfunction (such as intestinal ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K49/00
CPCA61K49/0008
Inventor 彭熙琳王远李玉婷刘杨王玉立罗杰黄磊
Owner DIAO GRP CHENGDU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products